ReviewFrontiers in immunology2024

m5C methylation modification may be an accomplice in colorectal cancer escaping from anti-tumor effects of innate immunity-type I/III interferon.

Yiqi Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.